Molecular Formula | C19H30ClN5O6 |
Molar Mass | 459.92 |
Melting Point | 271-274°C |
Boling Point | 664.5°C at 760 mmHg |
Flash Point | 355.7°C |
Solubility | Sparingly soluble in water, slightly soluble in methanol, very slightly soluble in ethanol (96 per cent), practically insoluble in acetone. |
Vapor Presure | 1.59E-17mmHg at 25°C |
Appearance | neat |
Color | White |
Storage Condition | Sealed in dry,Room Temperature |
MDL | MFCD00941408 |
Physical and Chemical Properties | Melting point 271-274°C |
Use | An α1-selective blocker |
In vitro study | In prostate cancer cells, Terazosin causes a significant loss of cell viability by inducing apoptosis. Terazosin inhibits prostate growth through α1-adrenoceptor independent action, further supporting another study, Doxazosin inhibits human vascular smooth muscle cell proliferation, independent of α1-adrenoceptor antagonism. In Xenopus oocytes, Terazosin blocked the HERG current with an IC 50 of 113.2 mM, while in human HEK293 cells, Terazosin blocked the HERG channel with an IC 50 of 17.7 mM. Terazosin or genistein inhibited DU-145 cell growth in a dose-dependent manner, while had no effect on normal prostatic epithelial cells. Terazosin caused genistein-induced DU-145 cell arrest at G2/M phase, an increase in apoptotic cells, as evidenced by procaspase-3 activation and PARP cleavage. Terazosin induced cytotoxicity in PC-3 and human benign prostate cells with an IC 50 of 100 mM. |
In vivo study | In nude mice, Terazosin significantly inhibited vascular endothelial growth factor-induced angiogenesis with an IC50 of 7.9 mM, showing that it has a more potent anti-angiogenic effect than the cytotoxic effect. Terazosin also effectively inhibited vascular endothelial growth factor-induced proliferation and tube formation in human umbilical vein endothelial cells with IC50 of 9.9 and 6.8 mM, respectively. |
Hazard Symbols | Xn - Harmful |
Risk Codes | 22 - Harmful if swallowed |
RTECS | TK8046000 |
HS Code | 2934990002 |
Toxicity | LD50 in male, female rats (mg/kg): 277, 293 i.v. (Fort) |
Reference Show more | 1. Zhang, Man, et al. "Micelles self-assembled by 3-O-β-d-glucopyranosyl latycodigenin enhance cell membrane permeability, promote antibiotic pulmonary targeting and improve anti-infective efficacy." Journal of nanobiotechnology 18.1 (2020): 1-15. |